Trial intelligence / Profile preview

Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis

NCT03667131Phase 2Completed

Sponsor
Universidad de Guadalajara
Start
Feb 2017
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Enalapril Maleate with Placebo (2 arms). Primary endpoint: Pulse Wave Velocity at 90 days. Started Feb 2017; status: completed.

02

Drugs

enalapril
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT03667131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03667131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call